Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
Q2 2022 vs. Q1 2022
How the institutions holding Prenetics Global Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 0 | 11 | +11 |
| Shares | 0 | 5.91M | +5.91M |
| Value | $0 | $23.9M | +$23.9M |
New holders (11)
Institutions that held Prenetics Global Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Aspex Management (HK) Ltd | 5,192,250 | $21.0M | 0.53% |
| Millennium Management LLC | 350,892 | $1.42M | 0.00% |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 244,868 | $989.0K | 0.77% |
| Nine Masts Capital Ltd | 49,949 | $202.0K | 0.05% |
| Fan Yu | 25,000 | $101.0K | 1.56% |
| Tower Research Capital LLC (TRC) | 12,290 | $50.0K | 0.00% |
| Oasis Management Co Ltd. | 11,732 | $47.0K | 0.01% |
| Citadel Advisors LLC | 11,740 | $47.0K | 0.00% |
| Penserra Capital Management LLC | 4,736 | $19.0K | 0.00% |
| Bank of America Corp | 1,654 | $7.00K | 0.00% |
| UBS Group AG | 1,704 | $7.00K | 0.00% |
Sold out (0)
Institutions that held Prenetics Global Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
None.